Track topics on Twitter Track topics that are important to you
WuXi Biologics has completed construction of its $150 million 30,000 liter biomanufacturing facility in
Stock Symbol: (HK: 2269)
Share this with colleagues:
Original Article: WuXi Biologics Opens Expanded $150 Million Biomanufacturing FacilityNEXT ARTICLE
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...
Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...